Abstract:Morbidity and mortality caused by invasive Aspergillus infections are increasing. This is because of the higher number of patients with malignancies treated with intensive immunosuppressive therapy regimens as well as their improved survival from formerly fatal bacterial infections, and the rising number of patients undergoing allogeneic haematopoietic stem cell or organ transplantation. Early initiation of effective systemic antifungal treatment is essential for a successful clinical outcome in these patients; however, clinical clues for diagnosis are sparse and early microbiological proof of invasive aspergillosis (IA) is rare. Clinical diagnosis is based on pulmonary CT scan findings and non-culture based diagnostic techniques such as galactomannan or DNA detection in blood or bronchoalveolar lavage samples. Most promising outcomes can be expected in patients at high risk for aspergillosis in whom antifungal treatment has been started pre-emptively, backed up by laboratory and imaging findings. The gold standard of systemic antifungal treatment is voriconazole, which has been proven to be significantly superior to conventional amphotericin B and has led to a profound improvement of survival rates in patients with cerebral aspergillosis. Liposomal amphotericin B at standard dosages appears to be a suitable alternative for primary treatment, while caspofungin, amphotericin B lipid complex or posaconazole have shown partial or complete response in patients who had been refractory to or intolerant of primary antifungal therapy. Combination therapy with two antifungal compounds may be a promising future strategy for first-line treatment. Lung resection helps to prevent fatal haemorrhage in single patients with pulmonary lesions located in close proximity to larger blood vessels, but is primarily considered for reducing the risk of relapse during subsequent periods of severe immunosuppression. Strict reverse isolation appears to reduce the incidence of aspergillosis in allogeneic stem cell transplant recipients and patients with acute myeloid leukaemia undergoing aggressive anticancer therapy. Well designed, prospective randomised studies on infection control measures effective to prevent aspergillosis are lacking. Prophylactic systemic antifungal treatment with posaconazole significantly improves survival and reduces IA in acute myeloid leukaemia patients and reduces aspergillosis incidence rates in patients with intermediate-to-severe graft-versus-host reaction emerging after allogeneic haematopoietic stem cell transplantation. Voriconazole prophylaxis may be suitable for prevention of IA as well; however, the results of large clinical trials are still awaited.

Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature

Aspergillus oryzae Isolated from Lung Tissue Sample in a Chronic Respiratory Illness Patient from South India

An immunocompetent lady with invasive aspergillosis presenting as disseminated lesions: a case report

Pulmonary Aspergillosis in People with Cystic Fibrosis

A Fatal Case of Trichosporon Asahii Fungemia and Pneumonia in a Kidney Transplant Recipient During Caspofungin Treatment.

The first case of Acrophialophora levis-induced severe pneumonia: a case report and literature review

Clinical Analysis on Ninty-Six Cases of Secondary Aspergillosis in COPD Patients

Aspergillus Coinfection in a Hydatid Cyst Cavity of Lung in an Immunocompetent Host: A Case Report and Review of Literature

Zoonotic fungus Arthroderma multifidum causing chronic pulmonary infection

Post covid-19 invasive pulmonary Aspergillosis: A case report

Fungal Respiratory Disease

Coinfection of Klebsiella pneumoniae and Aspergillus in a patient with chronic obstructive pulmonary disease post cardiac arrest: a case report

Invasive Pulmonary Aspergillosis in Patients with Chronic Obstructive Pulmonary Disease: a Case Report and Review of the Literature

Invasive aspergillosis in an immunocompetent patient: A retrospective case report and review of the literature

Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: Case report and literature review

A Case of Pulmonary MALToma Camouflaged Within Invasive Pulmonary Aspergillosis

Co-infection of Nocardia and Aspergillus fumigatus in a immunosuppressed patient: Case report

A Suppurative Thyroiditis and Perineal Subcutaneous Abscess Related with Aspergillus Fumigatus: a Case Report and Literature Review.

Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years

Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients

Invasive pulmonary aspergillosis in a patient with cirrhosis